The aim of our study was to measure concentrations of vascular endothelial growth factor (VEGF), platelet endothelial cell adhesion molecule-1 (PECAM-1) CD31 and vascular cell adhesion molecules (VCAM-1) in the follicular fluid of women treated with assisted reproduction technology to determine whether these proteins might be outcome markers. METHODS: Follicular fluid was collected from 75 patients ≤40 years undergoing oocyte retrieval procedures at our tertiary hospital during 1997 and 1998: 50 with tubal disease, 12 with endometriosis, and 13 whose partners had been diagnosed with severe oligoasthenoteratozoospermia. This retrospective analysis considered age and information about treatment and outcome for all these women who had undergone fewer than three assisted reproduction attempts. RESULTS: Nineteen women became pregnant (defined by human chorionic gonadotrophin concentrations and embryonic cardiac activity 1 month after follicular aspiration); 56 did not. Women did not differ significantly in their follicular fluid concentrations of VEGF, sCD31 and VCAM-1 according to cause of infertility, or assisted reproduction outcome, or age. Follicular fluid concentrations of VEGF were significantly correlated with the number of gonadotrophin ampoules administered (P < 0.012), and follicular fluid concentrations of sVCAM-1 with the fertilization rate (P < 0.01). Follicular fluid concentrations of VEGF and sVCAM-1 were also correlated (P < 0.007). CONCLUSIONS: Our results do not suggest that VEGF, CD31, or sVCAM-1 in follicular fluid predict assisted reproduction outcome, especially among patients ≤40 years old. The correlation of a high fertilization rate and sVCAM-1 in follicular fluid suggests that sVCAM-1 might be a marker of fertilization.
Introduction
Neulen Abramov et al., 1997; Elchalal and Schenker, 1997) .
Interest has recently focused on possible interactions between
In women with normal non-stimulated cycles and those cytokines, growth factors and mitogens in the ovary (Adashi, undergoing IVF, the local VEGF production in follicular fluid 1992; Moncayo and Moncayo, 1995; Elchalal and Schenker, (follicular fluid) is correlated with the degree of follicular 1997). Vascular endothelial growth factor (VEGF) is a heparinluteinization (Lee et al., 1997; Anasti et al., 1998) . Progesterone binding glycoprotein that enhances vascular permeability, is also appears to play a role in determining VEGF concentration mitogenic for endothelial cells and promotes angiogenesis in in follicular fluid (Moncayo et al., 1998) . A positive correlation normal and tumoral tissues (Ferrara et al., 1991 (Ferrara et al., , 1992 . In the has also been observed between follicular fluid VEGF concenovary, VEGF is produced both by granulosa and thecal cells trations and patient age, especially in patients ജ38 years (Ravindranath et al., 1992; Kamat et al., 1995) . Recent study undergoing IVF Manau et al., 2000) . of macaque granulosa cells suggests that VEGF expression Recently, it has been reported that elevated VEGF concentraincreases in response to gonadotrophins such as LH, FSH tions in follicular fluid might predict poor conception rates and human chorionic gonadotrophin (HCG) (Christenson and after IVF (Friedman et al., 1998) . . VEGF has been also implicated in the pathoPlatelet endothelial cell adhesion molecule-1 (PECAM-1 or genesis of capillary leakage, which in turn is a major CD31) and vascular cell adhesion molecule-1 (VCAM-1) are mechanism of ovarian hyperstimulation syndrome (OHSS), a severe complication of IVF procedures (Yan et al., 1993;  transmembrane glycoproteins belonging to the immunoglobulin Values are mean Ϯ SD unless otherwise indicated. The groups did not differ significantly for any parameter, as assessed using the Kruskal-Wallis test. VEGF ϭ vascular endothelial growth factor; sCD31 ϭ soluble platelet endothelial cell adhesion molecule-1; sVCAM-1 ϭ soluble vascular cell adhesion molecules.
not become pregnant after assisted reproduction (group 1). Pregnancy superfamily (Gearing et al., 1993; Almendro et al., 1996) .
(n ϭ 19, group 2) was defined by significant HCG concentrations and
These molecules are known to be essential mediators of white the observation of embryonic cardiac activity during the transvaginal blood cell adhesion and extravasation during inflammatory ultrasound examination performed 1 month after follicular aspiration.
and immune reactions (Marik and Lo, 1996; Cotran and Mayadas-Norton, 1998 (Daniel et al., 1999) . To our knowledge, concentration was Ͻ50 pg/ml, three ampoules of human menopausal VCAM-1 and CD31 have never been studied in follicular fluid.
gonadtotrophin (Menotropin, Humegon 75 IU; Organon, Saint-Denis,
The aim of our study was to assess the concentrations of 
Materials and methods
when the plasma oestradiol concentration was Ͼ1800 pg/ml and Follicular fluid was collected from 75 consecutive patients ഛ40 years when at least two follicles with a diameter of 20 mm were observed who were undergoing oocyte retrieval for IVF procedures at the by ultrasound examination, 10 000 IU of HCG was given i.m. Department of Obstetrics and Gynaecology in the Bichat Claude to induce follicular rupture. Transvaginal follicular aspiration was Bernard tertiary hospital during 1997 and 1998. performed 34-36 h after the HCG injection, under general anaesthesia using propofol (Diprivan; Zeneca, Cergy, France). After oocytes were Population identified and separated, the clear follicular fluid was collected and The 75 patients were divided into three groups according to the cause pooled for each woman. When blood contamination was observed, of their infertility: for 50 women it was due only to laparoscopically follicular fluid was discarded. This study considered follicular fluid confirmed tubal disease, without any male factors; 12 women had from only one cycle for each patient. All samples were immediately laparoscopy-proven severe endometriosis with no male factors and centrifuged at 400 g for 10 min and the supernatant stored frozen 13 women had partners diagnosed with severe oligoasthenoteratozooat -40°C until they were assayed. spermia that required intracytoplasmic sperm injection (ICSI). The records of all IVF and ICSI procedures were retrospectively reviewed Determination of VEGF, sVCAM-1 and sCD31 concentrations in to collect the following data: age, duration of stimulation, total follicular fluid ampoules of administered gonadotrophins, plasma oestradiol concentration on the day of HCG administration, number of retrieved These concentrations were assessed with the appropriate enzymelinked immunosorbent assay test kits for human VEGF, human oocytes, fertilization rate and pregnancy rate. None of them had more than three attempts at assisted reproduction and no patient was sVCAM-1, and human sCD31 (R&D Systems Minneapolis, USA). All samples were run in duplicate. For VEGF, VCAM-1 and CD31, included twice considering sequential cycles. Fifty-six women did all samples were diluted to 1/4, 1/20 and 1/5 respectively with the sensitivity of the test was 9 pg/ml. The intra-assay and inter-assay reproduction coefficients of variation (CV) were 3.5 and 7% respectively. For sVCAM-1, the sensitivity of the assay was 2 ng/ml, and the intraCharacteristics Groups t-Test assay and inter-assay CV were 5 and 9% respectively. Finally, for sCD31, the sensitivity of the assay was 0.05 ng/ml, and the intraMiscarriage Delivery P assay and inter-assay CV were 7 and 6% respectively. Values are mean Ϯ SD unless otherwise indicated. VEGF ϭ vascular endothelial growth factor; sCD31 ϭ soluble platelet previously observed (Friedman et al., 1998) , with the variance endothelial cell adhesion molecule-1; sVCAM-1 ϭ soluble vascular cell estimates they reported.
adhesion molecules.
Results
In this study, 15 patients were ജ38 years old. As Table IV  Table I summarizes the characteristics of the 75 patients. The shows, we compared them with the group of women Ͻ38 three groups defined according to the origin of their infertility years, and found no statistically significant differences in the did not differ significantly for any of the characteristics follicular fluid concentrations of VEGF, sCD31, or sVCAM-1. assessed: mean age, total number of gonadotrophin ampoules The only significant difference between the two groups conadministered, oestradiol concentration on day of HCG injeccerned the oestradiol peak on the day HCG was administered; tion, number of retrieved oocytes, and fertilization rate.
it was higher among the younger women. Similarly, they did not differ significantly with respect to Finally, the angiogenic factors (VEGF, CD31, and VCAM-1) follicular fluid concentrations of VEGF, sCD31 or sVCAM-1.
we examined were not significantly correlated with patient No patient in this study developed OHSS.
age, the number of oocytes retrieved, or the concentration of Moreover, the assisted reproduction outcome was not related oestradiol peak. As in recent studies (Friedman et al., 1998 ; to follicular fluid concentrations of VEGF, sCD31 or Manau et al., 2000) , follicular fluid concentrations of VEGF sVCAM-1. Group 1 (the 56 women who did not become were weakly but significantly correlated with the number of pregnant) and group 2 (the 19 women who did become gonadotrophin ampoules administered (P Ͻ 0.012) ( Figure  pregnant) did not differ significantly for any of these growth 1A). Follicular fluid concentrations of sVCAM-1 were also factor concentrations, as Table II shows. correlated with the fertilization rate (P Ͻ 0.01) ( Figure 1B ) Of the 19 women who became pregnant, five miscarried and the follicular fluid concentration of VEGF (P Ͻ 0.007) during the first trimester. The remaining pregnancies resulted ( Figure 1C ). in viable offspring. As with the previous comparisons, these two groups of women (14 who gave birth at term and five Discussion who had miscarriages) did not differ significantly in their follicular fluid concentrations of VEGF, sCD31 or sVCAM-1
Several authors have demonstrated that VEGF is produced by granulosa cells and released into the follicular fluid after (Table III) . Values are mean Ϯ SD unless otherwise indicated. VEGF ϭ vascular endothelial growth factor; sCD31 ϭ soluble platelet endothelial cell adhesion molecule-1; sVCAM-1 ϭ soluble vascular cell adhesion molecules.
gonadotrophin stimulation (Neulen et al., 1995; Christenson and Stouffer, 1997) . Recently, it was observed that follicular fluid concentrations of VEGF were positively correlated with patient age, in particular, for patients ജ38 years undergoing IVF . These authors subsequently observed a correlation between the follicular fluid concentration of VEGF and IVF outcome (conception rate) (Friedman et al., 1998) , with high concentrations associated with poor outcome. They therefore suggested that follicular fluid VEGF might be a marker of a decreased ovarian reserve and of a hostile follicular environment. Recently, the same positive correlation between high concentration of follicular fluid VEGF and the patient's age was reported (Manau et al., 2000) . Our study did not confirm their findings that VEGF concentrations are positively correlated with patient age and a low conception rate. Like them, we did observe a moderate increase in follicular fluid concentrations of VEGF in women ജ38 years old undergoing follicular aspiration, compared with younger women, but the difference was not statistically significant. Finally, in our study we obtained (-46.3; 1419.9) as 95% CI of the difference in the follicular fluid VEGF between groups 1 and 2 (Table II) which makes unlikely any such correlation with IVF outcome noted by Friedman et al. (1998) . Furthermore, we found no statistically significant correlation between the follicular fluid concentrations of sCD31 or sVCAM-1 and patient age. Our results also indicated that follicular fluid concentrations of VEGF, sCD31 and sVCAM-1 were similar for the three different causes of infertility studied, i.e. tubal factors, endometriosis, or male factors. This result must be fluid do not predict assisted reproduction outcome. However, Spearman's rank correlation (ρ) was determined. some authors (Van Blerkom et al., 1997) have shown that the VEGF measurements of follicular fluid indicated a potential role for this factor in perifollicular angiogenesis and in the regulation of intrafollicular oxygen concentrations. Therefore, sVCAM-1 does not appear to predict assisted reproduction outcome. Our data did, however, show a highly significant VEGF could be a marker for healthy individual follicle but not a clinical prognostic marker for the course of assisted positive relation between follicular fluid sVCAM-1 concentrations and the fertilization rate. This concentration might thus reproduction, which would be consistent with our results. Moreover, the other angiogenesis factors we tested here, sCD31 be a marker of fertilization. Besides the gonadotrophin-dependent production of VEGF and sVCAM-1, did not provide any additional information. It should nonetheless be borne in mind that the number of by granulosa cells, other indications that cytokine interactions may be involved in the local regulation of VEGF production pregnancies in our series was limited and our sample collection design pooled follicular fluid of each woman (as did Friedman have appeared in recent studies (Cohen et al., 1996; Moncayo et al., 1998) . We observed a significant positive correlation et al., 1998) and therefore did not allow identification of processes occurring in single follicles, which is a limitation of between follicular fluid concentrations of sVCAM-1 and of VEGF. Thus, follicular fluid local production of these factors our study. However, our data showed that there was no statistically significant difference in the follicular fluid VEGF appears to be linked. Finally, our study suggests that both these angiogenic factors (VEGF and VCAM-1) are probably concentrations in patients conceiving and those failing to conceive. This suggests that VEGF production by granulosa involved in fertilization, but their local regulation is currently unknown. cells is not directly correlated with assisted reproduction outcome or pregnancy potential.
VEGF has also been postulated to be a mediator of OHSS Conclusion (Elchalal and Shenker, 1997; Rizk et al., 1997) but not an
In conclusion, we found that VEGF, sCD31 and sVCAM-1 important clinical marker for the course of this condition concentrations in follicular fluid were not correlated with (Ludwig et al., 1998) . In this context, a recent study reports assisted reproduction outcome. We were also unable to confirm that follicular fluid concentrations of VEGF are higher than previous reports that follicular fluid concentrations of VEGF serum concentrations (Artini et al., 1998) . No patient in our are elevated in older women (ജ38 years) undergoing assisted study had clinical OHSS, and only four patients had an reproduction. Our results also indicated that follicular fluid oestradiol concentration that peaked at Ͼ3500 pg/ml on the concentrations of VEGF, sCD31 and sVCAM-1 were similar day of HCG administration. The moderate increase in the in women whose infertility stems from different causes (tubal follicular fluid concentration of VEGF in some patients, factors, endometriosis, or male factors). Finally, our data especially those ജ38 years old, might therefore simply reflect suggest that elevated follicular fluid sVCAM-1 concentration the variable ovarian response to gonadotrophin stimulation, may be associated with a high fertilization rate. Elevated rather than serve as a prognostic factor for assisted reproduction follicular fluid concentrations of sVCAM-1 appears therefore to outcome.
be a fundamental marker of the process of human fertilization. Of the various endothelial markers known, CD31, which corresponds to the intercellular adhesion molecule PECAM-1, has been widely used in immunohistochemical analysis of
